Literature DB >> 3693260

Protective effect of coenzyme Q10 on thyrotoxic heart in rabbits.

C Kotake1, Y Ito, M Yokoyama, H Fukuzaki.   

Abstract

An excess of thyroid hormone is known to produce cardiac dysfunction and failure, i.e., thyrotoxic heart. We studied the protective effect of coenzyme Q10 (CoQ10) on the thyrotoxic heart in 29 rabbits. A group treated with 1-thyroxine sodium salt (T4; 167 micrograms/kg) for 3 weeks showed marked decreases in the myocardial content of norepinephrine (NE) and ATP (0.5 +/- 0.2 microgram/g wet weight, P less than 0.05 and 31.1 +/- 2.6 nmol/mg protein, P less than 0.05, respectively) as compared with a group treated with CoQ10 solvent (2 ml/kg) for 3 weeks (1.1 +/- 0.1 microgram/g wet weight and 45.7 +/- 4.7 nmol/mg protein). The mitochondrial Ca2+ content of the T4 group showed significant increases (21.3 +/- 0.6 nmol/mg protein, P less than 0.05) compared with the solvent group (18.2 +/- 0.8 nmol/mg protein), while the total tissue Ca2+ content of the T4 group was unchanged compared with the solvent group. These biochemical derangements suggest that T4-treated rabbits were in a state of cardiac dysfunction. In contrast, a group which was assigned to concomitant treatment of T4 and CoQ10 (5 mg/kg) for 3 weeks showed no reductions in NE and ATP (0.9 +/- 0.2 micrograms/g wet weight and 44.6 +/- 1.9 nmol/mg protein, respectively) and protected an increase in the mitochondrial Ca2+ content (18.2 +/- 1.2 nmol/mg protein). A group treated with CoQ10 (5 mg/kg) for 3 weeks showed no changes in myocardial NE, ATP, and Ca2+ content in the mitochondria. These results suggest that exogenously administered CoQ10 may protect against biochemical derangements in the thyrotoxic heart.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693260     DOI: 10.1007/bf02058524

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Determinants of thyroxine-induced cardiac hypertrophy in mice.

Authors:  J Cohen; J M Aroesty; M G Rosenfeld
Journal:  Circ Res       Date:  1966-04       Impact factor: 17.367

2.  Intracellular calcium and myocardial contractility. IV. Distribution of calcium in the failing heart.

Authors:  Y Ito; C A Chidsey
Journal:  J Mol Cell Cardiol       Date:  1972-10       Impact factor: 5.000

3.  Evidence for a deficiency of coenzyme Q10 in human heart disease.

Authors:  K Folkers; G P Littarru; L Ho; T M Runge; S Havanonda; D Cooley
Journal:  Int Z Vitaminforsch       Date:  1970

4.  Depressed adenyl cyclase activity in the failing guinea pig heart.

Authors:  B E Sobel; P D Henry; A Robison; C Bloor; J Ross
Journal:  Circ Res       Date:  1969-04       Impact factor: 17.367

5.  Simultaneous determination of ubiquinone-10 and ubiquinol-10 in tissues and mitochondria by high performance liquid chromatography.

Authors:  K Katayama; M Takada; T Yuzuriha; K Abe; S Ikenoya
Journal:  Biochem Biophys Res Commun       Date:  1980-08-14       Impact factor: 3.575

6.  Cardiac failure in the dog as a consequence of exogenous hyperthyroidism.

Authors:  D Piatnek-Leunissen; R E Olson
Journal:  Circ Res       Date:  1967-02       Impact factor: 17.367

7.  Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts.

Authors:  Y Ito; J Suko; C A Chidsey
Journal:  J Mol Cell Cardiol       Date:  1974-06       Impact factor: 5.000

8.  Autonomic hyperactivity in patients with vasospastic angina.

Authors:  K Tamada; Y Ito; H Fukuzaki
Journal:  Jpn Heart J       Date:  1985-09

9.  Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.

Authors:  P H Langsjoen; S Vadhanavikit; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Superoxide radical generation, NADPH oxidase activity, and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation.

Authors:  V Fernández; X Barrientos; K Kipreos; A Valenzuela; L A Videla
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.